Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
2.00 x 1 2.25 x 6
Pre-market by (Cboe BZX)
2.19 +0.04 (+1.86%) 04/11/25 [NASDAQ]
2.00 x 1 2.25 x 6
Pre-market 2.19 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.03
Day High
2.19
Open 2.18
Previous Close 2.19 2.19
Volume 144,500 144,500
Avg Vol 316,585 316,585
Stochastic %K 42.47% 42.47%
Weighted Alpha -68.13 -68.13
5-Day Change +0.02 (+1.16%) +0.02 (+1.16%)
52-Week Range 1.93 - 12.34 1.93 - 12.34
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,046
  • Shares Outstanding, K 30,227
  • Annual Sales, $ 192,350 K
  • Annual Income, $ 2,990 K
  • EBIT $ 6 M
  • EBITDA $ 11 M
  • 60-Month Beta 1.09
  • Price/Sales 0.34
  • Price/Cash Flow 8.81
  • Price/Book 1.92

Options Overview Details

View History
  • Implied Volatility 233.12% ( +2.61%)
  • Historical Volatility 217.57%
  • IV Percentile 95%
  • IV Rank 45.43%
  • IV High 478.58% on 03/19/25
  • IV Low 28.80% on 05/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 542
  • Volume Avg (30-Day) 287
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 5,294
  • Open Int (30-Day) 3,372

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.93 +13.16%
on 04/07/25
Period Open: 7.00
5.14 -57.47%
on 03/12/25
-4.82 (-68.79%)
since 03/11/25
3-Month
1.93 +13.16%
on 04/07/25
Period Open: 7.83
8.45 -74.14%
on 01/27/25
-5.64 (-72.09%)
since 01/10/25
52-Week
1.93 +13.16%
on 04/07/25
Period Open: 12.14
12.34 -82.29%
on 04/17/24
-9.95 (-82.00%)
since 04/11/24

Most Recent Stories

More News
Why Zynex Plunged Today

Earnings and guidance disappointed, but the pullback could be an opportunity.

ZYXI : 2.18 (+1.63%)
Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex, Inc Sets Third Quarter 2023 Earnings Call

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex to Present at the Cantor Global Healthcare Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex Announces Share Repurchase Program

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex to Present at the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex Announces 1 Millionth Patient Milestone

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex, Inc Announces New Therapy Products

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)
Zynex Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.18 (+1.63%)

Business Summary

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and...

See More

Key Turning Points

3rd Resistance Point 2.41
2nd Resistance Point 2.30
1st Resistance Point 2.24
Last Price 2.18
1st Support Level 2.08
2nd Support Level 1.97
3rd Support Level 1.91

See More

52-Week High 12.34
Fibonacci 61.8% 8.36
Fibonacci 50% 7.13
Fibonacci 38.2% 5.91
Last Price 2.18
52-Week Low 1.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar